Free Trial

Omada Health (OMDA) Competitors

Omada Health logo
$20.53 +0.12 (+0.59%)
As of 08/15/2025 04:00 PM Eastern

OMDA vs. PGNY, CELC, LFST, PACS, ARDT, NHC, VRDN, AVAH, AHCO, and TDOC

Should you be buying Omada Health stock or one of its competitors? The main competitors of Omada Health include Progyny (PGNY), Celcuity (CELC), LifeStance Health Group (LFST), PACS Group (PACS), Ardent Health (ARDT), National HealthCare (NHC), Viridian Therapeutics (VRDN), Aveanna Healthcare (AVAH), AdaptHealth (AHCO), and Teladoc Health (TDOC). These companies are all part of the "healthcare" industry.

Omada Health vs. Its Competitors

Omada Health (NASDAQ:OMDA) and Progyny (NASDAQ:PGNY) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings.

Progyny has a net margin of 4.28% compared to Omada Health's net margin of 0.00%. Progyny's return on equity of 10.69% beat Omada Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Omada HealthN/A N/A N/A
Progyny 4.28%10.69%7.12%

In the previous week, Progyny had 14 more articles in the media than Omada Health. MarketBeat recorded 17 mentions for Progyny and 3 mentions for Omada Health. Omada Health's average media sentiment score of 1.06 beat Progyny's score of 0.77 indicating that Omada Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Omada Health
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Progyny
8 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

94.9% of Progyny shares are held by institutional investors. 9.4% of Progyny shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Progyny has higher revenue and earnings than Omada Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Omada HealthN/AN/AN/AN/AN/A
Progyny$1.24B1.62$54.34M$0.5939.66

Omada Health currently has a consensus price target of $24.57, indicating a potential upside of 19.69%. Progyny has a consensus price target of $24.90, indicating a potential upside of 6.41%. Given Omada Health's stronger consensus rating and higher probable upside, research analysts clearly believe Omada Health is more favorable than Progyny.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Omada Health
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00
Progyny
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

Summary

Progyny beats Omada Health on 8 of the 12 factors compared between the two stocks.

Get Omada Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OMDA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OMDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OMDA vs. The Competition

MetricOmada HealthMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.18B$7.55B$5.68B$9.81B
Dividend YieldN/A2.79%3.79%4.12%
P/E RatioN/A74.9431.0825.11
Price / SalesN/A30.43467.01193.48
Price / CashN/A25.7937.4059.05
Price / BookN/A17.309.096.18
Net IncomeN/A$243.10M$3.26B$265.11M
7 Day Performance7.94%3.01%7.36%4.21%
1 Month Performance10.97%1.52%5.47%2.01%
1 Year PerformanceN/A18.72%30.61%23.75%

Omada Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OMDA
Omada Health
N/A$20.53
+0.6%
$24.57
+19.7%
N/A$1.18BN/A0.00849
PGNY
Progyny
1.4748 of 5 stars
$21.85
-4.4%
$24.90
+13.9%
+12.2%$1.87B$1.17B37.01310
CELC
Celcuity
1.1211 of 5 stars
$45.76
-0.3%
$39.20
-14.3%
+228.4%$1.78BN/A-15.1040News Coverage
Earnings Report
Analyst Forecast
Short Interest ↑
LFST
LifeStance Health Group
3.2422 of 5 stars
$4.60
+5.1%
$8.50
+85.0%
-6.8%$1.77B$1.32B-91.1010,218
PACS
PACS Group
2.1353 of 5 stars
$11.25
+1.0%
$34.29
+204.8%
-71.2%$1.71B$3.11B0.0032,433
ARDT
Ardent Health
3.2589 of 5 stars
$11.93
+0.3%
$19.55
+63.9%
-26.5%$1.70B$5.97B6.5824,900
NHC
National HealthCare
N/A$103.57
+3.2%
N/A-17.1%$1.60B$1.37B12.9812,400Dividend Announcement
VRDN
Viridian Therapeutics
1.7465 of 5 stars
$16.67
+1.6%
$37.00
+122.0%
+24.3%$1.36B$305K-4.3650
AVAH
Aveanna Healthcare
1.9057 of 5 stars
$6.90
+12.4%
$6.10
-11.6%
+41.6%$1.35B$2.09B86.5633,500News Coverage
Analyst Forecast
High Trading Volume
AHCO
AdaptHealth
3.9948 of 5 stars
$9.23
+0.4%
$13.40
+45.2%
-7.3%$1.24B$3.26B17.0610,500Positive News
TDOC
Teladoc Health
3.2846 of 5 stars
$6.89
-1.1%
$9.76
+41.8%
+6.4%$1.22B$2.57B-5.795,500News Coverage
Positive News
Analyst Revision

Related Companies and Tools


This page (NASDAQ:OMDA) was last updated on 8/16/2025 by MarketBeat.com Staff
From Our Partners